ImmunoCellular Therapeutics (IMUC)

Add to Watchlists
Create an Alert
0.81 -0.14  -14.29% AMEX Sep 23, 4:59PM BATS Real time Currency in USD
View Full Chart
IMUC Price Chart
View All Events

IMUC Events

Date Type Description
08/07/2014 17:00 EDT Misc Q2 2014 Immunocellular Therapeutics Earnings Conference Call
08/07/2014 Earnings Q2 2014 Immunocellular Therapeutics Earnings Results
06/13/2014 Misc Annual General Meeting for ImmunoCellular Therapeutics Ltd
05/08/2014 17:00 EDT Misc Q1 2014 ImmunoCellular Therapeutics, Ltd. Earnings Conference Call
05/08/2014 Earnings Q1 2014 ImmunoCellular Therapeutics, Ltd. Earnings Results
03/13/2014 17:00 EDT Misc Q4 2013 ImmunoCellular Therapeutics, Ltd. Earnings Conference Call
03/13/2014 Earnings Q4 2013 ImmunoCellular Therapeutics, Ltd. Earnings Results
11/06/2013 17:00 EDT Misc Q3 2013 ImmunoCellular Therapeutics, Ltd. Earnings Conference Call
11/06/2013 Earnings Q3 2013 ImmunoCellular Therapeutics, Ltd. Earnings Results
View All Performance Charts

IMUC Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ImmunoCellular Therapeutics is down 70.00% over the last year vs S&P 500 Total Return up 18.38%, Celldex Therapeutics down 53.64%, and Northwest Biotherapeutics up 48.00%.

Get Quote for
Advertisement

Portfolio Strategies Featuring IMUC

Did ImmunoCellular Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

IMUC Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.imuc.com
  • IR Website: http://investors.imuc.com/
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2013
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Sector: Professional, Scientific, and Technical Services

ImmunoCellular Therapeutics Limited is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.

IMUC Excel Add-In Codes

  • Name: =YCI("IMUC","name")
  • Description: =YCI("IMUC","description")
  • Sector: =YCI("IMUC","sector")
  • Industry: =YCI("IMUC","industry")
  • Est. Current Fiscal Year End: =YCI("IMUC","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.